HLA and killer cell immunoglobulin-like receptors influence the natural course of CMV infection. - Wikidata - wikimedia - TriplyDB

HLA and killer cell immunoglobulin-like receptors influence the natural course of CMV infection.

HLA and killer cell immunoglobulin-like receptors influence the natural course of CMV infection.

http://www.wikidata.org/entity/Q42224225

about

Activating KIRs and NKG2C in Viral Infections: Toward NK Cell Memory?Host genetics and susceptibility to congenital and childhood cytomegalovirus infection: a systematic review Recipient-donor KIR ligand matching prevents CMV reactivation post-haploidentical T cell-replete transplantation.KIR2DL3 and the KIR ligand groups HLA-A-Bw4 and HLA-C2 predict the outcome of hepatitis B virus infection.Severe Symptomatic Primary Human Cytomegalovirus Infection despite Effective Innate and Adaptive Immune Responses.High prevalence of specific KIR types in patients with HHV-8 positive cutaneous vascular lesions: a possible predisposing factor?Association between γ marker, human leucocyte antigens and killer immunoglobulin-like receptors and the natural course of human cytomegalovirus infection: a pilot study performed in a Sicilian population.HLA and killer cell immunoglobulin-like receptor (KIRs) genotyping in patients with acute viral encephalitis.

P2860

Q26776114-41285F4D-4C4C-4E9D-B10F-BA863DC8E976 Q37307250-9F1F631B-5535-4059-B012-3A1C83FB4755 Q40217725-02DE2E33-E37B-472E-AFE6-114C7D13D707 Q40328386-5E9989D9-09E4-47B4-9FEB-EC6593FD536B Q40392303-F1670581-A304-480E-803B-3750D211A9DD Q40722451-30A12284-5F27-4AFB-8DF7-FD8D8B0F95A2 Q47601337-DCF0BD93-6A9C-426C-B036-A82109D4357B Q55334485-D8FF34BE-2890-4911-8294-A60167D39BCB

P2860

HLA and killer cell immunoglobulin-like receptors influence the natural course of CMV infection.

http://www.wikidata.org/entity/Q42224225

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

HLA and killer cell immunoglob ...... tural course of CMV infection.

@en

HLA and killer cell immunoglob ...... tural course of CMV infection.

@nl

type

label

HLA and killer cell immunoglob ...... tural course of CMV infection.

@en

HLA and killer cell immunoglob ...... tural course of CMV infection.

@nl

prefLabel

HLA and killer cell immunoglob ...... tural course of CMV infection.

@en

HLA and killer cell immunoglob ...... tural course of CMV infection.

@nl

P1433

Q42224225-CFB86086-F143-46CC-8552-02C8A9A2C68F

P1476

Q42224225-4A2B2409-2BD8-4941-8702-6DA99DB115A1

P2093

Q42224225-26B82BAF-9F45-4980-BBC6-DE6AE3D5AE75

Q42224225-31F45F74-DD54-4F8E-BB24-82AD0C73BC9F

Q42224225-3F9B5701-E2C9-40F2-884C-E32CEB656DFF

Q42224225-5C8654BC-0B38-42DA-96AF-B1F41C0C1D19

Q42224225-6C1731EC-1643-4291-8751-A9E29096A368

Q42224225-8B1E3451-ED57-4140-9D4E-A2A26E49DD34

Q42224225-EDF1B1AD-8CD5-4670-BF07-2F9407239082

P2860

Q42224225-088CA196-622A-4DA7-94D7-BCF78E2BD1B6

Q42224225-250726DE-FC35-4CBD-962A-E4A0A2B8E63E

Q42224225-29B07718-7611-4213-ADE0-C5DFB4D5A0C7

Q42224225-3CCC61E7-BF5A-44C3-B293-153379C236A0

Q42224225-48C3CF79-8D35-497F-B1C6-8B7F0CA882C6

Q42224225-519B0426-C8F9-48C3-A31A-A604AD0B9744

Q42224225-67A1D38B-C073-4BA2-84F8-F09F6B7FBE78

Q42224225-89055EE2-9AE3-4377-BAAD-210475FE710D

Q42224225-8F1AF9DA-7236-4D87-B561-6DF7F6F1B866

Q42224225-9AA1AE28-5759-4F8D-9B04-9EEEE18262CD

P304

Q42224225-8B47BC4F-A0F6-4728-A4F0-F3A3CE22587E

P31

Q42224225-2563F76D-60DB-4A8F-B8EF-1031C276BAC4

P356

Q42224225-30672926-5AE8-4D30-BD90-B11013FE8024

P407

Q42224225-00E5668F-5BDE-4651-843D-4231C4C47652

P433

Q42224225-7007616D-A770-49AE-8A72-52AE3E2A7B70

P478

Q42224225-012BD87C-1401-4DC9-B06A-052E332D50E1

P50

Q42224225-1062DFE9-E94F-4DB2-865B-4336F6B8F9E8

Q42224225-359F802D-A81B-4DAE-8054-1983EFEB4560

Q42224225-7443ECB2-D2CE-41DC-955B-8A6AFCE9C5B3

Q42224225-CF2245D7-675B-4CB1-8DF3-9D486BCE8961

Q42224225-D362EB64-0D7A-41D6-8D20-46B02DB1F54E

Q42224225-FB33EAEE-B29B-42D5-84F0-8164B38F0B4A

P577

Q42224225-066143BB-8D2A-4FEF-B47D-8DD7FC0E1FA7

P5875

Q42224225-22FADAE8-0DD2-4820-B650-21F33E87D3D5

P698

Q42224225-8A59229A-09E3-4A07-827B-0E4CFC3FE518

P356

P1433

The Journal of Infectious Diseases

P1476

HLA and killer cell immunoglob ...... atural course of CMV infection

@en

P2093

Antonella Plaia

http://www.w3.org/2001/XMLSchema#string

Calogero Caruso

http://www.w3.org/2001/XMLSchema#string

Cecilia Occhino

http://www.w3.org/2001/XMLSchema#string

Claudia Colomba

http://www.w3.org/2001/XMLSchema#string

Danilo Di Bona

http://www.w3.org/2001/XMLSchema#string

Giovanni Duro

http://www.w3.org/2001/XMLSchema#string

Valeria Scafidi

http://www.w3.org/2001/XMLSchema#string

P2860

Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS

KIR/HLA pleiotropism: protection against both HIV and opportunistic infections

NK cell recognition

Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1.

Human immunosenescence: is it infectious?

Differential natural killer cell-mediated inhibition of HIV-1 replication based on distinct KIR/HLA subtypes.

NK3-specific natural killer cells are selectively inhibited by Bw4-positive HLA alleles with isoleucine 80.

The Yin and Yang of HLA and KIR in human disease

Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection.

Approaches to minimize infection risk in blood banking and transfusion practice.

P304

1083-1089

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/INFDIS/JIU226

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

210

http://www.w3.org/2001/XMLSchema#string

P50

Antonino Tuttolomondo

Giovanni Maurizio Giammanco

Giuseppe Montalto

Marco Cippitelli

Simona De Grazia

P577

2014-04-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

261744982

http://www.w3.org/2001/XMLSchema#string

P698

24737799

http://www.w3.org/2001/XMLSchema#string